Press Releases

Please click here if you wish to receive an e-mail notification regarding Alector press releases.

Sep 12, 2022

Alector Initiates Phase 1 Clinical Trial of AL044 for the Treatment of Alzheimer’s Disease (AD)

Sep 07, 2022

Alector to Participate in Upcoming Healthcare Conferences

Aug 04, 2022

Alector Reports Second Quarter 2022 Financial Results and Provides Business Update

Jun 08, 2022

Alector to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference

May 27, 2022

Alector Reports Inducement Grants as permitted by the Nasdaq Listing Rules

May 05, 2022

Alector Reports First Quarter 2022 Financial Results and Provides Business Update

May 04, 2022

Alector to Participate at the BofA Securities 2022 Healthcare Conference

Mar 29, 2022

Alector Announces Appointment of Gary Romano, M.D., Ph.D., as Chief Medical Officer

Mar 15, 2022

Alector Presents AL001 (latozinemab) Data from the FTD-C9orf72 Cohort of the INFRONT-2 Phase 2 Clinical Trial

Mar 09, 2022

Alector to Present at Upcoming Healthcare Conferences
Displaying 1 - 10 of 16

Close

Are you sure you want to leave?

You are about to leave the Alector site. Please note our privacy policy won’t apply to these third-party sites.

Continue
Cancel